Devenir volontaire / Becoming a volunteer
  • Home
  • About us
    • Our Story
    • Our Culture
    • Scientific Advisory Board
    • Job offers
    • News
  • Services
    • Clinical trials
    • Central Lab
    • Microbiome
    • Sample Provider
    • Biometrics
    • Data Science
    • Consulting & Strategic Innovation
  • Resources
    • Scientific Publications
    • Case Studies
    • Scientific Booklet
  • Scientific Corner
    • Microbiome
    • Health
    • Nutrition
  • Get in touch
[ARTICLE] The intestinal microbiota, a major player in colorectal cancer 

[ARTICLE] The intestinal microbiota, a major player in colorectal cancer 

by Administrateur Biofortis | Mar 28, 2025 | Health, Microbiome

The colorectal cancer (CRC) ranks among the top 3 most frequent and deadly cancers in both men and women. Although the gut microbiota plays a pivotal role in maintaining intestinal homeostasis and overall health, recent research suggests its significant involvement in...
[CASE STUDY] GI disorders​

[CASE STUDY] GI disorders​

by Administrateur Biofortis | Nov 20, 2024 | Case studies_Clinical

Case study in Clinical trials Randomised, placebo-controlled, double-blinded study to evaluate the effects of a dietary supplement on gastrointestinal (GI) symptoms in subjects affected by GI disorders See all the case studiesGet in touch Key information Study...
[CASE STUDY] Evaluation of the efficacy, safety, and dose-response of a Live Biotherapeutic Product in women with acute vaginal infection

[CASE STUDY] Evaluation of the efficacy, safety, and dose-response of a Live Biotherapeutic Product in women with acute vaginal infection

by Administrateur Biofortis | Oct 1, 2024 | Case studies_Clinical

Case study in Clinical trials Evaluation of the efficacy, safety, and dose-response of a Live Biotherapeutic Product in women with acute vaginal infection: A randomized, double-blind, placebo-controlled study. See all the case studiesGet in touch Key information Study...
[CASE STUDY] Evaluation of the safety and preliminary efficacy in patients with constipation

[CASE STUDY] Evaluation of the safety and preliminary efficacy in patients with constipation

by Administrateur Biofortis | Oct 1, 2024 | Case studies_Clinical

Case study in Clinical trials Evaluation of the safety and preliminary efficacy in patients with constipation due to the use of opioid-based medications for the management of chronic non cancer pain. A randomized placebo-controlled study See all the case studiesGet in...
[ARTICLE] Measurement of body composition: concept and tools

[ARTICLE] Measurement of body composition: concept and tools

by Administrateur Biofortis | Oct 27, 2021 | Health, Nutrition

As developed in our previous article on  , the type of data obtained are useful for diagnosis, managing and understanding different physiological conditions such as weight loss, sarcopenia or others disease risk factors. Concept Analysis of body composition is based...
Page 1 on 212»

Our latest articles

  • [EVENT] Biofortis, membre du comité d’organisation et Sponsor Silver de la Journée Nutrition & Microbiote 2025 September 23, 2025
  • [EVENT] – Biofortis and analyze & realize will be present at Vitafoods Europe 2025 April 1, 2025
  • [ARTICLE] The intestinal microbiota, a major player in colorectal cancer  March 28, 2025
  • [PRESS RELEASE] Biofortis and Teranga strengthen their service offerings with the acquisition of NEOVIX group  March 7, 2025
  • [ARTICLE] Kefir and Kombucha: are health promises justified? February 27, 2025
  • [EVENT] Biofortis and analyze&realize will be present at IPA World Congress + Probiota 2025 January 8, 2025

Biofortis, your CRO partner for your clinical trials and microbiome expertise

ABOUT US

Our story

Our job offers

Privacy Policy

Cookies management

Legal Notice

CONTACT

biofortis-contact@biofortis.fr

Devenir volontaire

3 Route de la Chatterie

44800 Saint-Herblain – France

+33 (0) 2 40 20 57 99